Google previews public online health service

Share this article:
Google Health goes live
Google Health goes live

Google last week unveiled its new online health service at a meeting of the Healthcare Management and Information Systems Society (HIMSS) in Orlando.

Although the service has not yet been made available to the public, a pilot version is being tested by a select group of Cleveland Clinic patients. Functions of the service dubbed Google Health are expected to include storage of medical records, health tools and a find a doctor function.

Google CEO Eric Schmidt compared Google Health to Google's news service, which, to date, does not carry advertising.

“Our model is that the owner of the data has control over who can see it,” Schmidt said at the HIMMS conference. “And trust, for Google, is the most important currency on the Internet.”

Google may not need to place its ads directly on the its health landing page as long as it provides a search box that can lead users to other pages with advertising.

Google's VP, search & user products, Marissa Mayer, wrote in a recent blog post: “We're proud of the product that we've designed and are continuing to build…We look forward to the feedback we will receive from our Cleveland Clinic pilot, from all of you, and from the initial users of our service when we make it publicly available in the coming months.”

The full contents of Mayer's blog post are available here.
 

Share this article:
You must be a registered member of MMM to post a comment.

Email Newsletters

MM&M Future Leaders


Register now

Early bird $1,950 before 31 October 2014

*Group discounts available on request 

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...